H2S-releasing polymer micelles for studying selective cell toxicity

Molecular Pharmaceutics

Volumn 14, Issue 4, 2017, Pages 1300-1306

  Foster, Jeffrey C ^a   Radzinski, Scott C ^a   Zou, Xianlin ^b   Finkielstein, Carla V ^b   Matson, John B ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b VIRGINIA BIOINFORMATICS INSTITUTE   (United States)

Author keywords

Controlled release; Gasotransmitter; H2S donors; Polymer amphiphiles; RAFT

Indexed keywords

COPOLYMER; DRUG VEHICLE; HYDROGEN SULFIDE; METHYLENE BLUE; CYSTEINE; GYY 4137; MICELLE; MORPHOLINE DERIVATIVE; PHOSPHOROTHIOIC ACID DERIVATIVE; POLYMER; SODIUM SULFIDE; SULFIDE;

ANIMAL CELL; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL PROLIFERATION; CELL VIABILITY; COLON CANCER CELL LINE; COLORECTAL CARCINOMA; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; CYTOTOXICITY; DRUG RELEASE; EMBRYO; FIBROBLAST; MICELLIZATION; MOLECULE; NONHUMAN; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; POLYMERIZATION; PRIORITY JOURNAL; REFRACTION INDEX; ANIMAL; CELL LINE; CHEMISTRY; DRUG EFFECTS; HALF LIFE TIME; HCT 116 CELL LINE; HUMAN; KINETICS; MICELLE; MOUSE; NIH 3T3 CELL LINE; TUMOR CELL LINE;

ANIMALS; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CYSTEINE; HALF-LIFE; HCT116 CELLS; HUMANS; HYDROGEN SULFIDE; KINETICS; MICE; MICELLES; MORPHOLINES; NIH 3T3 CELLS; ORGANOTHIOPHOSPHORUS COMPOUNDS; POLYMERS; SULFIDES;

EID: 85019048605     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/acs.molpharmaceut.6b01117     Document Type: Article

References (46)

1. 2S be the third endogenous gaseous transmitter? FASEB J. 2002, 16 (13), 1792-1798.
2. Mustafa, A. K.; Gadalla, M. M.; Snyder, S. H. Signaling by Gasotransmitters. Sci. Signaling 2009, 2 (68), re2.
3. Wang, R. Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed. Physiol. Rev. 2012, 92 (2), 791-896.
4. Szabo, C. Hydrogen sulphide and its therapeutic potential. Nat. Rev. Drug Discovery 2007, 6 (11), 917-935.
5. Papapetropoulos, A.; Pyriochou, A.; Altaany, Z.; Yang, G.; Marazioti, A.; Zhou, Z.; Jeschke, M. G.; Branski, L. K.; Herndon, D. N.; Wang, R.; Szabo, C. Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 2009, 106 (51), 21972-21977.
6. Calvert, J. W.; Coetzee, W. A.; Lefer, D. J. Novel Insights Into Hydrogen Sulfide-Mediated Cytoprotection. Antioxid. Redox Signaling 2010, 12 (10), 1203-1217.
7. Kashfi, K.; Olson, K. R. Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras. Biochem. Pharmacol. 2013, 85 (5), 689-703.
8. Shibuya, N.; Koike, S.; Tanaka, M.; Ishigami-Yuasa, M.; Kimura, Y.; Ogasawara, Y.; Fukui, K.; Nagahara, N.; Kimura, H. A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells. Nat. Commun. 2013, 4, 1366.
9. 2S over Biological Thiols. J. Am. Chem. Soc. 2013, 135 (44), 16697-16704.
10. Montoya, L. A.; Pluth, M. D. Selective turn-on fluorescent probes for imaging hydrogen sulfide in living cells. Chem. Commun. 2012, 48 (39), 4767-4769.
11. 2S) with Diselenides: The Application in the Design of Fluorescent Probes. Org. Lett. 2015, 17 (6), 1541-1544.
12. Lin, V. S.; Chen, W.; Xian, M.; Chang, C. J. Chemical probes for molecular imaging and detection of hydrogen sulfide and reactive sulfur species in biological systems. Chem. Soc. Rev. 2015, 44 (14), 4596-4618.
13. Zhang, H.; Kong, X.; Tang, Y.; Lin, W. Hydrogen Sulfide Triggered Charge-Reversal Micelles for Cancer-Targeted Drug Delivery and Imaging. ACS Appl. Mater. Interfaces 2016, 8 (25), 16227-39.
14. 2S) donors. J. Am. Chem. Soc. 2011, 133, 15-17.
15. Wallace, J. L. Hydrogen sulfide-releasing anti-inflammatory drugs. Trends Pharmacol. Sci. 2007, 28 (10), 501-505.
16. Kodela, R.; Chattopadhyay, M.; Kashfi, K. NOSH-Aspirin: A Novel Nitric Oxide-Hydrogen Sulfide-Releasing Hybrid: A New Class of Anti-inflammatory Pharmaceuticals. ACS Med. Chem. Lett. 2012, 3 (3), 257-262.
17. Foster, J. C.; Powell, C. R.; Radzinski, S. C.; Matson, J. B. S-Aroylthiooximes: A Facile Route to Hydrogen Sulfide Releasing Compounds with Structure-Dependent Release Kinetics. Org. Lett. 2014, 16 (6), 1558-1561.
18. Devarie-Baez, N. O.; Bagdon, P. E.; Peng, B.; Zhao, Y.; Park, C.-M.; Xian, M. Light-Induced Hydrogen Sulfide Release from "Caged" gem-Dithiols. Org. Lett. 2013, 15 (11), 2786-2789.
19. 2S) releasing agents: chemistry and biological applications. Chem. Commun. 2014, 50 (80), 11788-11805.
20. Chattopadhyay, M.; Kodela, R.; Nath, N.; Dastagirzada, Y. M.; Velazquez-Martinez, C. A.; Boring, D.; Kashfi, K. Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: A general property and evidence of a tissue type-independent effect. Biochem. Pharmacol. 2012, 83 (6), 715-722.
21. Li, L.; Whiteman, M.; Guan, Y. Y.; Neo, K. L.; Cheng, Y.; Lee, S. W.; Zhao, Y.; Baskar, R.; Tan, C.-H.; Moore, P. K. Characterization of a Novel, Water-Soluble Hydrogen Sulfide-Releasing Molecule (GYY4137). Circulation 2008, 117 (18), 2351-2360.
22. Szczesny, B.; Módis, K.; Yanagi, K.; Coletta, C.; Le Trionnaire, S.; Perry, A.; Wood, M. E.; Whiteman, M.; Szabo, C. AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro. Nitric Oxide 2014, 41, 120-130.
23. Wu, D.; Si, W.; Wang, M.; Lv, S.; Ji, A.; Li, Y. Hydrogen sulfide in cancer: Friend or foe? Nitric Oxide 2015, 50, 38-45.
24. Lee, Z. W.; Teo, X. Y.; Tay, E. Y. W.; Tan, C. H.; Hagen, T.; Moore, P. K.; Deng, L. W. Utilizing hydrogen sulfide as a novel anticancer agent by targeting cancer glycolysis and pH imbalance. Br. J. Pharmacol. 2014, 171 (18), 4322-4336.
25. Filomeni, G.; Aquilano, K.; Rotilio, G.; Ciriolo, M. R. Reactive Oxygen Species-dependent c-Jun NH2-terminal Kinase/c-Jun Signaling Cascade Mediates Neuroblastoma Cell Death Induced by Diallyl Disulfide. Cancer Res. 2003, 63 (18), 5940-5949.
26. Cairns, R.; Papandreou, I.; Denko, N. Overcoming Physiologic Barriers to Cancer Treatment by Molecularly Targeting the Tumor Microenvironment. Mol. Cancer Res. 2006, 4 (2), 61-70.
27. Szabo, C.; Coletta, C.; Chao, C.; Módis, K.; Szczesny, B.; Papapetropoulos, A.; Hellmich, M. R. Tumor-derived hydrogen sulfide, produced by cystathionine-β-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer. Proc. Natl. Acad. Sci. U. S. A. 2013, 110 (30), 12474-12479.
28. Chemistry, Biochemistry and Pharmacology of Hydrogen Sulfide; Springer International Publishing: Switzerland, 2015; Vol. 230.
29. 2S-Releasing Polymers. Macromolecules 2014, 47 (15), 5089-5095.
30. Hasegawa, U.; van der Vlies, A. J. Design and Synthesis of Polymeric Hydrogen Sulfide Donors. Bioconjugate Chem. 2014, 25 (7), 1290-1300.
31. Carter, J. M.; Qian, Y.; Foster, J. C.; Matson, J. B. Peptide-based hydrogen sulphide-releasing gels. Chem. Commun. (Cambridge, U. K.) 2015, 51 (66), 13131-13134.
32. Long, T. R.; Wongrakpanich, A.; Do, A.-V.; Salem, A. K.; Bowden, N. B. Long-term release of a thiobenzamide from a backbone functionalized poly(lactic acid). Polym. Chem. 2015, 6 (40), 7188-7195.
33. Qian, Y.; Matson, J. B. Gasotransmitter delivery via self-assembling peptides: Treating diseases with natural signaling gases. Adv. Drug Delivery Rev. 2016, DOI: 10.1016/j.addr.2016.06.017.
34. Nguyen, M. M.; Carlini, A. S.; Chien, M.-P.; Sonnenberg, S.; Luo, C.; Braden, R. L.; Osborn, K. G.; Li, Y.; Gianneschi, N. C.; Christman, K. L. Enzyme-Responsive Nanoparticles for Targeted Accumulation and Prolonged Retention in Heart Tissue after Myocardial Infarction. Adv. Mater. 2015, 27 (37), 5547-5552.
35. Ambade, A. V.; Savariar, E. N.; Thayumanavan, S. Dendrimeric Micelles for Controlled Drug Release and Targeted Delivery. Mol. Pharmaceutics 2005, 2 (4), 264-272.
36. Willcock, H.; O'Reilly, R. K. End group removal and modification of RAFT polymers. Polym. Chem. 2010, 1 (2), 149-157.
37. Matson, J. B.; Grubbs, R. H. Synthesis of Fluorine-18 Functionalized Nanoparticles for use as in vivo Molecular Imaging Agents. J. Am. Chem. Soc. 2008, 130 (21), 6731-6733.
38. Siegel, L. M. A direct microdetermination for sulfide. Anal. Biochem. 1965, 11 (1), 126-132.
39. Feng, S.; Zhao, Y.; Xian, M.; Wang, Q. Biological thiols-triggered hydrogen sulfide releasing microfibers for tissue engineering applications. Acta Biomater. 2015, 27, 205-213.
40. Kelner, M. J.; Alexander, N. M. Methylene blue directly oxidizes glutathione without the intermediate formation of hydrogen peroxide. J. Bio. Chem. 1985, 260 (28), 15168-15171.
41. Sawhney, R. S.; Zhou, G.-H. K.; Humphrey, L. E.; Ghosh, P.; Kreisberg, J. I.; Brattain, M. G. Differences in Sensitivity of Biological Functions Mediated by Epidermal Growth Factor Receptor Activation with Respect to Endogenous and Exogenous Ligands. J. Biol. Chem. 2002, 277 (1), 75-86.
42. Awwad, R. A.; Sergina, N.; Yang, H.; Ziober, B.; Willson, J. K. V.; Zborowska, E.; Humphrey, L. E.; Fan, R.; Ko, T. C.; Brattain, M. G.; Howell, G. M. The Role of Transforming Growth Factor α in Determining Growth Factor Independence. Cancer Res. 2003, 63 (15), 4731-4738.
43. Wang, J.; Sun, L.; Myeroff, L.; Wang, X.; Gentry, L. E.; Yang, J.; Liang, J.; Zborowska, E.; Markowitz, S.; Willson, J. K. V.; Brattain, M. G. Demonstration That Mutation of the Type II Transforming Growth Factor β Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma Cells. J. Biol. Chem. 1995, 270 (37), 22044-22049.
44. Rajput, A.; Dominguez San Martin, I.; Rose, R.; Beko, A.; LeVea, C.; Sharratt, E.; Mazurchuk, R.; Hoffman, R. M.; Brattain, M. G.; Wang, J. Characterization of HCT116 Human Colon Cancer Cells in an Orthotopic Model. J. Surg. Res. 2008, 147 (2), 276-281.
45. Todaro, G. J.; Green, H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 1963, 17 (2), 299-313.
46. 2S Releasing Nanofibrous Coating for In Vivo Dermal Wound Regeneration. ACS Appl. Mater. Interfaces 2016, 8 (41), 27474-27481.